S-1/A XBRL

AMENDMENT NO. 1 TO REGISTRATION STATEMENT

Company: RELMADA THERAPEUTICS, INC.
Filed: February 26, 2019
Accession Number: 0001213900-19-003153

View Document ↗ View on SEC.gov ↗